G

Genovis AB
STO:GENO

Watchlist Manager
Genovis AB
STO:GENO
Watchlist
Price: 28.05 SEK 3.13% Market Closed
Market Cap: 1.8B SEK
Have any thoughts about
Genovis AB?
Write Note

Genovis AB
Long-Term Debt

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Genovis AB
Long-Term Debt Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Long-Term Debt CAGR 3Y CAGR 5Y CAGR 10Y
G
Genovis AB
STO:GENO
Long-Term Debt
kr75.1m
CAGR 3-Years
N/A
CAGR 5-Years
91%
CAGR 10-Years
N/A
AddLife AB
STO:ALIF B
Long-Term Debt
kr2.9B
CAGR 3-Years
129%
CAGR 5-Years
195%
CAGR 10-Years
N/A
BICO Group AB
STO:BICO
Long-Term Debt
kr1.9B
CAGR 3-Years
178%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Biotage AB
STO:BIOT
Long-Term Debt
kr217m
CAGR 3-Years
80%
CAGR 5-Years
8%
CAGR 10-Years
47%
MedCap AB (publ)
STO:MCAP
Long-Term Debt
kr296.1m
CAGR 3-Years
19%
CAGR 5-Years
12%
CAGR 10-Years
33%
M
Magle Chemoswed Holding AB
STO:MAGLE
Long-Term Debt
kr37.2m
CAGR 3-Years
5%
CAGR 5-Years
148%
CAGR 10-Years
N/A
No Stocks Found

Genovis AB
Glance View

Market Cap
1.8B SEK
Industry
Life Sciences Tools & Services

Genovis AB engages in the research and development of enzyme products. The company is headquartered in Lund, Skane. The company went IPO on 2005-11-11. The firm offers products within two product portfolios, namely protein portfolio and nano portfolio. The protein portfolio develops products within the areas of cancer, inflammatory and autoimmune diseases. The portfolio comprises FabRICATOR, a genetically modified enzyme the cleaves antibodies in two parts, and IgGZERO, a protein that specifically cleaves the sugar molecules that occur naturally on antibodies. The products within the nano portfolio are primarily directed at the preclinical market. The firm markets and sells its products through dealers and distributors in the European, North American and Asian continents. As of December 31, 2011, it operated a wholly owned subsidiary, Eijdo Research AB.

GENO Intrinsic Value
24.64 SEK
Overvaluation 12%
Intrinsic Value
Price
G

See Also

What is Genovis AB's Long-Term Debt?
Long-Term Debt
75.1m SEK

Based on the financial report for Jun 30, 2024, Genovis AB's Long-Term Debt amounts to 75.1m SEK.

What is Genovis AB's Long-Term Debt growth rate?
Long-Term Debt CAGR 5Y
91%

Over the last year, the Long-Term Debt growth was 1 551%.

Back to Top